These aberrantly expressed miRNAs target crucial genes in CLL, such as ATM and TP53, which are involved in important pathways, such as RNA transport, the cell cycle, mTOR and p53 signaling. The gene discussed is TP53; the disease is B-cell chronic lymphocytic leukemia.